---
layout: single
author_profile: true
title: "Business Trip Report - Korea @ Sep-2025"
date: Sun Jan  05 02:30:00 PST 2026
last_modified_at: Sun Jan  05 02:30:00 PST 2026
permalink: /report/biz-trip/2025/sep
categories:
 - report
tags:
 - business trip
toc: true
toc_label: "&nbsp;Table of Contents"
toc_icon: "fa-solid fa-music"
toc_sticky: true
---

posted: {{ page.date| date: "%d-%b-%Y" }}
&amp;
updated: {{ page.last_modified_at| date: "%d-%b-%Y" }}
{: .notice--primary}

# Trip Overview

**Korea â€¢ September 14-27, 2025 â€¢ Sunghee Yun**

Landmark 13-night trip featuring breakthrough VC engagement and Silicon Valley network expansion. During this trip, Sunghee
- secured **Path Way Investment commitment for Series A**
- obtained **StartX program endorsement from Andrew Radin** (AI Head @ StartX)
- worked on **â‚©500M angel investment** from Jinsul Joo
- delivered highly successful AI seminars at **POSTECH, Korea University Business School, and SNU EE**
- participated in **3-day G-Quantum Bio Forum** with critical networking outcomes
- gained comprehensive regulatory and legal insights for medical device approval
- expanded Korean medicine (í•œì˜í•™) collaboration network

# Basic Logistics

**Dates:** September 14-27, 2025 (13 nights)

**Flights:**
- **Outbound:** OZ 211, SFO â†’ ICN (departed Sep 14 @ 11:30pm PDT, arrived Sep 16 @ 4:30am KST)
- **Return:** OZ 212, ICN â†’ SFO (departed Sep 27 @ 8:55pm KST, arrived Sep 27 @ 3:30pm PDT)

**Base:** ìˆ˜ì§€ (Suji), Seoul

**Regional Trips:**
- **Sep 17:** Day trip to Pohang
  - KTX-ì‚°ì²œ 4031: Gwangmyeong Station â†’ Pohang Station (8:54am â†’ 10:55am)
  - KTX-ì‚°ì²œ 254: Pohang Station â†’ Gwangmyeong Station (9:36pm â†’ 11:48pm)
- **Sep 22-24:** 2-night stay in Suwon for G-Quantum Bio Forum
  - Base: Courtyard Marriott Suwon

# KEY MEETINGS & OUTCOMES

## 16-Sep-2025 - Strategic Planning & Business Development

### **Evening (7:00pm-8:30pm): Business Development Networking Dinner**

<h3>Attendee</h3>

- **ì´ìƒì—½** (Vice Chairman, Korea SME Association - í•œêµ­ê°•ì†Œê¸°ì—…í˜‘íšŒ)

<h3>Outcomes</h3>

- Established potential network contact for Erudio Bio business development
- Identified influential connection throughout í•œêµ­ê°•ì†Œê¸°ì—…í˜‘íšŒ
- He has his own startup with novel ideas - potential synergies

### **After Dinner: Strategic Meeting with Jin Young Heo**

<h3>Attendees</h3>

- Sunghee Yun
- Jin Young Heo (CLO, Erudio Bio Korea)

<h3>Discussion Topics</h3>

- General Erudio Bio strategies (SNUBH, Jeonbuk progress review)
- **G-Quantum Bio Conference planning** (Sep 22-24 @ Suwon Convention Center)
  - Jin Young to attend Day 2 (Sep 23)
  - Sunghee to invite Jin Young to K-BioX mentoring sessions, G-BIVA í˜ì‹  ì‚´ë¡±, dinner

---

## 17-Sep-2025 - POSTECH AI Seminar & Robotics Collaboration

**Location:** Pohang University of Science and Technology (POSTECH)

<h3>Event</h3>

AI seminar for POSTECH students

<h3>Networking Dinner</h3>

**Attendee:**
- **Prof. í•œìˆ˜í¬** (Associate Professor, Creative IT Engineering / Electrical Engineering; Director, Unmanned Vehicle Research Institute, POSTECH)

<h3>Outcomes</h3>

- Gained deep insights into:
  - Robotics technology trends
  - Edge computing applications
  - AI technology developments in robotics field
- Proposed potential collaboration with Erudio Bio
- Fruitful conversation providing valuable AI/robotics trend insights

---

## 18-Sep-2025 - Dual AI Seminars: Major Academic Engagement

### **Morning: Korea University Business School (KUBS)**

**Title:** "The AI Revolution - How Smart Systems Are Reshaping Industries and Executive Decision-Making"

**Invited by:** Prof. ê¹€ê¸°í›ˆ (Professor, Graduate School of Business, Korea University)

**Abstract:** [Link](https://sungheeyun.github.io/seminars/2025_0918%20KST%20-%20KUBS%20Special%20AI%20Lecture%20-%20The%20AI%20Revolution%20-%20How%20Smart%20Systems%20Are%20Reshaping%20Industries%20and%20Executive%20Decision-Making/abstract)

<h3>Lunch Meeting with Prof. ê¹€ê¸°í›ˆ</h3>

**Discussion:** Potential collaboration with Erudio Bio & K-PAI

<h3>Outcome</h3>

Established relationship with KUBS for potential partnerships

---

### **Afternoon: SNU EE ì‚¬ê³¼ì„¸ë¯¸ë‚˜ - BREAKTHROUGH EVENT**

**Title:** "AI Pulse Check - What Silicon Valley Is Actually Building Right Now"

**Invited by:** Prof. í™ìš©íƒ (Professor & Department Chair, Electrical and Computer Engineering, Seoul National University)

**Abstract:** [Link](https://sungheeyun.github.io/seminars/2025_0918%20KST%20-%20SNU%20ECS%20Four-Departments%20Joint%20Seminar%20-%20AI%20Pulse%20Check%20-%20What%20Silicon%20Valley%20Is%20Actually%20Building%20Right%20Now/abstract)

<h3>Pre-Seminar Activity</h3>

15-minute tea time with Prof. í™ìš©íƒ

<h3>CRITICAL OUTCOMES - EXTREMELY SUCCESSFUL EVENT</h3>

- **Exceptional audience engagement:**
  - Strong eye contact and active participation throughout
  - Numerous insightful questions during seminar
  - **Long line of attendees post-seminar** wanting to:
    - Introduce themselves personally
    - Exchange contact information
    - Establish ongoing professional connections

<h3>Dinner Meeting</h3>

**Attendees:**
- Prof. í™ìš©íƒ
- **Prof. ê¹€ì˜ë¯¼** (Associate Professor, Electrical and Computer Engineering, Seoul National University)

<h3>Discussion & Outcomes</h3>

- Explored collaboration opportunities for Erudio Bio and K-PAI
- Gained valuable academic insights from SNU professors

---

### **Evening (9:15pm-11:30pm): Semiconductor Industry Deep Dive**

<h3>Attendee</h3>

- **ì±„ê´€ì—½** (Master, S.LSI Digital IP Development Team, Samsung Electronics)

<h3>Outcomes</h3>

Gained comprehensive insights into semiconductor business landscape:
- HBM (High Bandwidth Memory) business dynamics
- Samsung and worldwide foundry business
- Current and future AI landscape implications for semiconductor industry

---

## 19-Sep-2025 - Media Relations & Medical Equipment Regulatory Strategy

### **2:30pm-4:00pm: Media Interview - STRATEGIC INVESTMENT**

<h3>Attendee</h3>

- **ê¹€ì†Œì—°** (Deputy Manager, Information Media Science, Money Today)

<h3>Discussion</h3>

- Comprehensive AI landscape overview
- Differentiated insights unique to Sunghee's Silicon Valley perspective
- Agreement to meet again in Silicon Valley

<h3>CRITICAL OUTCOMES</h3>

- **Article published:** [Naver News Article](https://n.news.naver.com/article/008/0005264969?type=journalists)
- **Major follow-up article:** [Gates Foundation Erudio Bio Interview](https://www.mt.co.kr/tech/2025/12/15/2025121200524048774)
- **Strategic assessment:** Significant media exposure investment that paid off

---

### **Afternoon: Coffee Chat - Gauss Labs Alumni Network**

<h3>Attendee</h3>

- **ì´ë³‘ì°¬** (Former Senior Applied Scientist at Gauss Labs; currently Postdoc under Prof. ì‹ ì§„ìš°, KAIST)

<h3>Purpose</h3>

General networking, maintain Gauss Labs alumni connections

---

### **Evening: Medical Equipment Distribution & Regulatory Insights**

<h3>Attendees</h3>

- **ì´í™êµ­** (CEO, Asia Medical - ì•„ì‹œì•„ë©”ë””ì¹¼)
- **ê¹€ì •êµ­** (Director, Regional Media Support / Newspaper Distribution Team, Korea Press Foundation)
- **Jin Young Heo** (CLO, Erudio Bio Korea)

**Arranged by:** ì„±íƒœì›… (Sunghee's middle school friend)

<h3>CRITICAL OUTCOMES & INSIGHTS</h3>

- **Product categorization identified:** Erudio's VSA platform is categorized as **biochip medical equipment**
- **Regulatory pathway clarity:** Must investigate MFDS (KFDA) approval procedures specifically for biochip medical equipment
- **Documentation requirements:** Need to understand MFDS product definition and categories for proper regulatory pathway
- **Industry veteran perspective:** 20 years distribution experience provided invaluable market insights

**Assessment:** Extremely fruitful, instructive, helpful, and informative meeting

---

## 20-Sep-2025 - Angel Investment Finalization & IRB Strategy

### **9:00am-10:30am: Angel Investment Breakfast - MAJOR WIN**

<h3>Attendee</h3>

- **Jinsul Joo** (Angel investor)

<h3>CRITICAL OUTCOME</h3>

- Meeting initiated relationship
- Multiple follow-up meetings conducted
- **Eventually led to â‚©500M (500 million won) angel investment in Erudio Bio Korea, Inc.**

---

### **Phone Call: IRB Process Strategy**

<h3>Attendee</h3>

- **ì†¡ì¬ì§„** (Associate Professor, Clinical Medicine, Seoul National University Bundang Hospital)

<h3>CRITICAL STRATEGIC INSIGHT</h3>

- IRB approval is **iterative process**
- **Key recommendation:** Don't aim for perfection on first submission
- **Action:** Submit first draft to SNUBH to initiate conversation and process flow

---

### **Lunch: Recruitment Networking**

<h3>Attendee</h3>

- **ìœ¤ì„±í¬** (Recruiter)

<h3>Purpose</h3>

Potential recruitment support and general networking

---

### **Evening: Industry Networking Dinner**

<h3>Attendees</h3>

- **ì´ê²½í™˜** (CEO, KHAN; former Samsung employee)
- **ë°•ì¤€ì˜** (CEO, í•œë°˜ë„; Yonsei Engineering, Economics MA, Cultural Anthropology PhD; Samsung Electronics Technology Advisory Professor for Semiconductor)
- **ìµœìš±** (Team Leader PM&SE, BOS Semiconductors)
- **ì—„íš¨ì„­** (Team Leader, Innovation Talent Development Center, Incheon National University; bio/medical business involvement)

<h3>Outcome</h3>

- Received medical equipment booklet from ì—„íš¨ì„­
- Delivered booklet to Jin Young Heo same evening for review

---

### **Night: Customer Story Development**

**Location:** Jin Young Heo's house

<h3>Attendees</h3>

- Jin Young Heo (CLO, Erudio Bio Korea)
- í™©í˜œë ¨ (Jin Young's wife)
- Sunghee Yun

<h3>Purpose</h3>

Develop customer story narratives for business development materials

---

## 21-Sep-2025 - Press Strategy & Korean Medicine Collaboration

### **Lunch: Press Strategy Planning**

<h3>Attendees</h3>

- **ì¡°ì‹œì˜** (Team Leader, Securities Capital Markets IB Team, Asia Economy)
- Jin Young Heo (CLO, Erudio Bio Korea)
- Sunghee Yun

<h3>CRITICAL DECISION & STRATEGY</h3>

- **Press strategy:** Expose Erudio Bio to media as frequently as possible
- **Action decided:** Prepare press materials and deliver to ì¡°ì‹œì˜

---

### **Afternoon: AI/Cryptography Collaboration**

<h3>Attendee</h3>

- **ê¹€ì„¤ê¸°** (AI Â· Privacy Â· Data Consultant)

<h3>Purpose</h3>

Explore potential AI/cryptography collaboration and general networking

---

### **Evening (6:00pm-7:30pm): Korean Medicine Collaboration**

<h3>Attendees</h3>

- **ì •ìœ ìš©** (Senior Vice President, Korean Medical Association - ëŒ€í•œí•œì˜ì‚¬í˜‘íšŒ)
- **í™ìŠ¹í›ˆ** (Senior Engineer, SK Hynix)
- Sunghee Yun

<h3>Discussion</h3>

- Potential collaboration opportunities in í•œì˜í•™ (Korean traditional medicine)
- **Strategic note:** í•œì˜í•™ is unique medical science class existing only in South Korea
- Represents untapped market opportunity

---

## 22-Sep-2025 - 24-Sep-2025: G-Quantum Bio Forum - LANDMARK EVENT

**Location:** Suwon Convention Center  
**Duration:** 3-day forum

### **22-Sep-2025 (Day 1): Forum Opening & Networking**

<h3>Daytime</h3>

Attended cutting-edge bio/medical technology & research presentations

<h3>Evening: Networking Dinner</h3>

**Attendees:**
- Multiple public servants (forum organizers, planners, executors)
- CEOs and CTOs from bio/medical fields

<h3>Outcomes</h3>

- Established connections with forum organizers
- Networked with bio/medical industry leaders
- Met **ê¹€ì„±ì§„** (Manager, Suwon City Government)

<h3>Post-Dinner Activity</h3>

- Suwon castle and city night tour
- Experienced beautiful nighttime landscape of historic Suwon

---

### **23-Sep-2025 (Day 2) - BREAKTHROUGH DAY**

**Morning: K-BioX Mentoring Event**

<h3>CRITICAL MEETING: Andrew Radin (AI Head, StartX) - MAJOR STRATEGIC WIN</h3>

**Meeting Type:** In-person, face-to-face, personal meeting

<h3>CRITICAL OUTCOMES</h3>

1. **StartX Program Endorsement:**
   - Andrew Radin **personally advised Sunghee to apply for StartX program**
   - Andrew's endorsement **essentially guarantees acceptance**
   - Major Silicon Valley accelerator validation

2. **Successful Pitch Execution:**
   - Emphasized Erudio Bio's technical excellence
   - Highlighted entrepreneurial strength
   - Showcased strategic positioning
   - Presented business model
   - **Featured Gates Foundation Award prominently**
   - **Self-assessment:** "I did quite well on that pitch!"

3. **Strategic Impact:**
   - Connection to one of Silicon Valley's most influential AI leaders
   - Path to premier accelerator program
   - Validation from top-tier Silicon Valley ecosystem

---

<h3>Silicon Valley Network Expansion</h3>

**Introduced by Sunghee to Jin Young Heo:**
- **ì´ì‹œì—°** (K-BioX Representative Operating Committee Member, Stanford Medical School)
- **ìœ¤ì„±ì›** (Senior Navigation Engineer, Intuitive)
- **ë°•êµ°í˜¸** (CEO, PathoBrainSeq)

<h3>Outcome</h3>

Expanded Jin Young's Silicon Valley network with key biotech contacts

---

<h3>Special Lunch (Invitee-Only)</h3>

- Sunghee secured Jin Young Heo's attendance through special request
- Executive-level networking opportunity

---

<h3>Afternoon: G-BIVA í˜ì‹  ì‚´ë¡± (Exclusive Invitees-Only Event)</h3>

- Sunghee secured Jin Young Heo's attendance through special permission
- Presented Erudio Bio, Inc. to exclusive audience
- Learned from other CEOs' presentations
- High-level strategic discussions

---

<h3>Evening: Conference Main Dinner</h3>

- Extensive networking with students and K-BioX members
- Post-dinner: Special Suwon village tour

---

### **24-Sep-2025 (Day 3): Regulatory & Legal Deep Dive**

**All-Day Event: Regulatory Science Conference and Legal Strategy Seminar**

**Format:** Virtual attendance (all day)

**Attendees:**
- Sunghee Yun (virtual)
- Jin Young Heo (virtual)

**Program:** [PDF](https://sungheeyun-photos-01.github.io/resource/2025/09/22-24%20-%20G-Quantum%20Bio/program/Program%20-%20Regulatory%20Science%20Conference%20and%20Legal%20Strategy%20Seminar.pdf)

<h3>Morning Session (10:00-12:10): ê·œì œê³¼í•™ ì»¨í¼ëŸ°ìŠ¤</h3>

- Bioequivalence and regulatory guidelines
- Research development for regulatory approval
- AI application in drug development processes

<h3>Afternoon Session (13:30-16:30): ë²•ë¥  ì „ëµ ì„¸ë¯¸ë‚˜</h3>

- IPO and legal strategies for biotech companies
- IP licensing and legal frameworks
- Data/privacy legal considerations
- Investment structures and exit strategies

<h3>CRITICAL OUTCOMES</h3>

Comprehensive understanding of:
- **MFDS/KFDA regulatory pathways** for medical devices
- Legal frameworks for biotech companies in Korea
- IP strategy for medical device commercialization
- Investment and exit planning considerations
- All relevant regulatory requirements for Erudio Bio's product category

---

<h3>Evening: Recruitment Strategy</h3>

**Attendee:**
- **ì¡°ì—°í¬** (TL/Talent Acquisition Specialist, SK Hynix; former Gauss Labs recruiter)
- Sunghee Yun

<h3>Purpose</h3>

Explore potential collaboration for Erudio Bio Korea recruitment needs

---

## 25-Sep-2025 - Venture Capital Breakthrough & Strategic Partnerships

### **Path Way Investment VC Meeting - LANDMARK OUTCOME**

**Location:** 425 Eonju-ro, Gangnam District, Seoul

<h3>Attendees</h3>

- **Erudio Bio:**
  - Sunghee Yun
- **Path Way Partners/Investment:**
  - **ì´ìƒì§„** (CEO, Path Way Partners)
  - **ë¬¸ì´ˆí˜œ** (Executive Director / Ph.D. Engineering / Adjunct Professor, Molecular Medicine & Biopharmaceuticals, Seoul National University, Path Way Investment)
  - **ë°•ìœ¤í˜¸** (Deputy Director, Investment Planning / Research Analyst, Path Way Partners)

**Scheduled Duration:** 60 minutes  
**Actual Duration:** **110 minutes** (engagement so strong no one noticed time)

<h3>CRITICAL OUTCOMES</h3>

1. **Technology Deep Dive & Business Model Expansion:**
   - ë¬¸ì´ˆí˜œ Executive Director asked highly sophisticated technology questions
   - **AUDACIOUS BUSINESS MODEL PROPOSED:**
     - **Beyond lead optimization stage** (current assumption)
     - **VSA could contribute to preclinical stage**
     - **VSA could even contribute to clinical stage**
   - **Strategic impact:** Significantly expands Erudio Bio's total addressable market

2. **Series A Commitment:**
   - Several days post-meeting: Received text from **ì´ìƒì§„ CEO**
   - **Path Way confirmed interest in participating in Erudio Bio Series A fundraising round**

3. **Strategic Validation - MAJOR WINS:**
   - Confirmed market responds **very favorably** to Erudio Bio
   - Validated tech/market strategy is sound and compelling
   - Added high-caliber Korean VC to investor network
   - Expanded understanding of VSA platform's market potential

**Assessment:** Meeting exceeded all expectations - technology validation, business model expansion, and investor commitment achieved

---

### **Evening: Pion Corporation Partnership Exploration**

<h3>Dinner Attendees</h3>

- **ì „ì°¬ì„** (CEO, VCAT.AI, Pion Corporation)
- Jin Young Heo (CLO, Erudio Bio Korea)
- Sunghee Yun

<h3>Purpose</h3>

- General networking
- Explore potential technical partnership with Pion Corporation

---

### **Night: Semiconductor Industry Insights (Part 2)**

**Location:** ì±„ê´€ì—½'s house

<h3>Attendees</h3>

- **ì±„ê´€ì—½** (Master, S.LSI Digital IP Development Team, Samsung Electronics)
- Jin Young Heo
- Sunghee Yun

<h3>Purpose</h3>

Continued semiconductor industry insights and networking (follow-up to Sep 18 meeting)

---

## 26-Sep-2025 - Angel Investment Finalization & Korean Medicine AI Initiative

### **Lunch: D.notitia Partnership Discussion**

<h3>Attendees</h3>

- **ì •ë¬´ê²½** (CEO, D.notitia)
- **ì†ì¤€í˜** (COO / VP / Co-Founder, D.notitia)
- Jin Young Heo
- Sunghee Yun

<h3>Purpose</h3>

General networking and explore potential partnership opportunities

---

### **Evening: Angel Investment Terms Finalization**

<h3>Attendee</h3>

- **Angel Investor** (Jinsul Joo - USD 140k commitment)
- Sunghee Yun

<h3>CRITICAL OUTCOME</h3>

- Discussed and finalized investment terms
- Obtained investor's specific requests
- **Immediately communicated details to Kee-hyun Paik** for execution

---

### **Night: ëŒ€í•œí•œì˜ì‚¬í˜‘íšŒ AI TF Meeting - MAJOR ENGAGEMENT**

**Event:** [ëŒ€í•œí•œì˜ì‚¬í˜‘íšŒ] ì œ2íšŒ í•œì˜ì•½ AI ìœµí•© ì¶”ì§„ TF íšŒì˜

**Role:** ëŒ€í•œí•œì˜ì‚¬í˜‘íšŒ AI TF ìë¬¸ìœ„ì› (AI Task Force Advisory Committee Member)

<h3>Activity</h3>

- Delivered AI talk to Korean Medicine Association AI Task Force
- **Response:** Amazing engagement from all ìœ„ì› (committee members)

<h3>Attendees Met</h3>

- Multiple í•œì˜ì‚¬ (Korean medicine doctors)
- í•œë°©ë³‘ì› ì›ì¥ë‹˜ë“¤ (Korean medicine hospital directors)
- AI Task Force members

<h3>Post-Meeting Networking</h3>

- Participated in chicken & beer networking session
- Further relationship building with Korean medicine community

<h3>Outcome</h3>

Deepened engagement with Korean medicine AI integration initiative - unique market opportunity

---

## 27-Sep-2025 - Humanities & Social Sciences Networking, Return to US

### **Morning/Afternoon: Humanities & Social Sciences Gathering**

**Invited by:** James Rhee (Johnson Chair of Entrepreneurship; Owner, CEO, and Author @ red helicopter)

<h3>Attendees</h3>

- Professors and academics
- Humanities and social sciences experts

<h3>Discussion</h3>

ì¸ë¬¸ì‚¬íšŒê³¼í•™ì  (humanities and social sciences) issues and perspectives

<h3>Purpose</h3>

General networking, interdisciplinary perspective building

---

### **Evening: Return to Silicon Valley**

Flight: OZ 212, ICN â†’ SFO (departed 8:55pm KST, arrived 3:30pm PDT same day)

---

# FUNDRAISING

## Angel Investment Secured - USD 140k

**Investor:** Jinsul Joo

**Timeline:**
- Sep 20: Initial breakfast meeting
- Sep 26: Terms finalized
- **Amount:** USD 140,000

**Status:** <span style="color: green;">**Terms finalized, pending execution**</span>

---

## Angel Investment Secured - â‚©500M

**Investor:** Jinsul Joo

**Timeline:**
- Sep 20: Initial breakfast meeting initiated relationship
- Multiple follow-up meetings conducted
- **Amount:** â‚©500,000,000 (500 million won)

**Status:** <span style="color: green;">**Secured for Erudio Bio Korea, Inc.**</span>

---

## Series A Commitment - Path Way Investment

**Investor:** Path Way Partners/Investment

**Key Contact:** ì´ìƒì§„ (CEO)

**Timeline:**
- Sep 25: Initial meeting (110-minute deep dive)
- Post-meeting: Text confirmation of Series A interest

**Status:** <span style="color: blue;">**Commitment obtained, timing TBD**</span>

---

# PARTNERSHIP

## StartX Program - Silicon Valley Accelerator

**Contact:** Andrew Radin (AI Head, StartX)

**Outcome:** Personal endorsement and application recommendation (essentially guarantees acceptance)

**Status:** <span style="color: red;">**Pending application submission**</span>

---

## Korean Medicine AI Integration

**Organization:** ëŒ€í•œí•œì˜ì‚¬í˜‘íšŒ (Korean Medical Association)

**Role:** AI TF ìë¬¸ìœ„ì› (AI Task Force Advisory Committee Member)

**Status:** <span style="color: blue;">**Active ongoing engagement**</span>

---

## Pion Corporation Technical Partnership

**Contact:** ì „ì°¬ì„ (CEO, VCAT.AI, Pion Corporation)

**Status:** <span style="color: blue;">**Initial discussion, exploring opportunities**</span>

---

## D.notitia Partnership

**Contacts:** ì •ë¬´ê²½ (CEO), ì†ì¤€í˜ (COO/VP/Co-Founder)

**Status:** <span style="color: blue;">**Initial discussion, exploring opportunities**</span>

---

# NETWORKING

## POSTECH Faculty Network

**Contact:** Prof. í•œìˆ˜í¬ (Associate Professor, Director of Unmanned Vehicle Research Institute, POSTECH)

**Focus:** Robotics, edge computing, AI technology collaboration potential

---

## Korea University Business School (KUBS)

**Contact:** Prof. ê¹€ê¸°í›ˆ (Professor, Graduate School of Business)

**Focus:** K-PAI and Erudio Bio collaboration opportunities

---

## Seoul National University (SNU) EE Department

**Contacts:**
- Prof. í™ìš©íƒ (Department Chair, Electrical and Computer Engineering)
- Prof. ê¹€ì˜ë¯¼ (Associate Professor, Electrical and Computer Engineering)

**Outcome:** Extremely successful seminar with exceptional audience engagement, extensive post-seminar networking

---

## Silicon Valley-Korea Bridge

**G-Quantum Bio Forum Connections:**
- ì´ì‹œì—° (K-BioX Representative, Stanford Medical School)
- ìœ¤ì„±ì› (Senior Navigation Engineer, Intuitive)
- ë°•êµ°í˜¸ (CEO, PathoBrainSeq)

---

## Media Relations

**Contact:** ê¹€ì†Œì—° (Deputy Manager, Money Today)

**Outcome:** Two published articles including Gates Foundation feature

---

## Korean SME Association

**Contact:** ì´ìƒì—½ (Vice Chairman, í•œêµ­ê°•ì†Œê¸°ì—…í˜‘íšŒ)

**Potential:** Business development network throughout Korean SME ecosystem

---

## Recruitment Network

**Contacts:**
- ìœ¤ì„±í¬ (Recruiter)
- ì¡°ì—°í¬ (TL/Talent Acquisition Specialist, SK Hynix; former Gauss Labs)

---

## Humanities & Social Sciences

**Contact:** James Rhee (Johnson Chair of Entrepreneurship @ red helicopter)

**Network:** Professors and experts in humanities and social sciences

---

# ACTION ITEMS

| Owner | Deliverable | Deadline | Status |
|-------|-------------|----------|--------|
| Sunghee Yun | **Submit StartX program application** with Andrew Radin's endorsement | Q4-2025 | <span style="color: red;">**Pending**</span> |
| Sunghee Yun / Kee-hyun Paik | **Execute USD 140k angel investment** (Jinsul Joo) - terms finalized | Oct-2025 | <span style="color: blue;">In Progress</span> |
| Jin Young Heo | **Investigate MFDS biochip medical equipment approval process** - specific procedures and documentation requirements | Oct-2025 | <span style="color: blue;">In Progress</span> |
| Jin Young Heo | **Submit first draft IRB proposal to SNUBH** - initiate iterative process (per ì†¡ì¬ì§„'s advice) | Oct-2025 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Prepare press materials for ì¡°ì‹œì˜** (Asia Economy) - execute frequent media exposure strategy | Ongoing | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Follow up with Path Way Investment** on Series A timeline and requirements | Q4-2025/Q1-2026 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Coordinate with SNU EE faculty** (í™ìš©íƒ, ê¹€ì˜ë¯¼) on K-PAI and Erudio Bio collaboration | Q4-2025 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Follow up with Prof. í•œìˆ˜í¬** (POSTECH) on robotics/AI collaboration potential | Q4-2025 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Meet ê¹€ì†Œì—°** (Money Today) in Silicon Valley as discussed | Q1-2026 | <span style="color: red;">Pending</span> |
| Jin Young Heo | **Develop customer story narratives** based on Sep 20 meeting with í™©í˜œë ¨ | Oct-2025 | <span style="color: blue;">In Progress</span> |
| Sunghee Yun / Jin Young Heo | **Apply regulatory/legal insights from G-Quantum Bio seminar** to MFDS approval strategy | Ongoing | <span style="color: blue;">In Progress</span> |
| Sunghee Yun | **Explore Pion Corporation technical partnership** with ì „ì°¬ì„ | Q4-2025 | <span style="color: red;">Pending</span> |
| Sunghee Yun | **Continue Korean Medicine AI TF advisory role** and explore collaboration models | Ongoing | <span style="color: green;">Active</span> |

---

# MILESTONES & TIMELINE

**Immediate (Sep-Oct 2025):**
- âœ… Andrew Radin StartX endorsement obtained
- âœ… Path Way Investment Series A commitment secured
- âœ… USD 140k angel investment terms finalized
- âœ… â‚©500M angel investment secured for Korea entity
- âœ… Comprehensive MFDS/KFDA regulatory pathway understanding achieved
- âœ… Biochip medical equipment categorization confirmed
- ğŸ”„ StartX application submission
- ğŸ”„ SNUBH IRB first draft submission (iterative process initiated)
- ğŸ”„ MFDS approval process investigation

**Short-term (Q4 2025):**
- StartX program application and acceptance
- Angel investments execution (USD 140k + â‚©500M)
- MFDS biochip medical equipment regulatory pathway defined
- SNUBH IRB approval progress (iterative submissions)
- Press materials prepared and distributed
- Korean Medicine AI collaboration model developed

**Medium-term (2026):**
- Series A fundraising round with Path Way Investment participation
- MFDS approval process initiated for VSA platform
- K-PAI and academic collaborations formalized (SNU, POSTECH, KUBS)
- Korean Medicine AI integration pilot projects
- Silicon Valley-Korea network expansion leveraged

---

# STRATEGIC INSIGHTS

1. **Silicon Valley Validation - StartX Endorsement:**
   - Andrew Radin's personal endorsement represents top-tier Silicon Valley validation
   - StartX acceptance would provide premier accelerator credentials
   - Opens doors to Stanford ecosystem and Silicon Valley investor network
   - Demonstrates Erudio Bio's standing among elite Silicon Valley AI/biotech companies

2. **Venture Capital Market Validation:**
   - Path Way Investment's Series A commitment validates market appetite
   - 110-minute meeting duration (vs. 60-minute schedule) indicates genuine investor interest
   - Executive Director ë¬¸ì´ˆí˜œ's audacious business model proposal (preclinical + clinical stage expansion) significantly enlarges TAM
   - Korean VC market receptivity extremely positive

3. **Academic Network as Strategic Asset:**
   - SNU EE seminar's exceptional success (long post-event networking line) demonstrates strong academic community engagement
   - Multiple top-tier universities engaged (SNU, POSTECH, KUBS, KAIST connections)
   - Academic partnerships provide:
     - Research collaboration potential
     - Talent pipeline access
     - Credibility and validation
     - K-PAI platform expansion opportunities

4. **Regulatory Pathway Clarity:**
   - Biochip medical equipment categorization is critical for proper MFDS approval pathway
   - G-Quantum Bio Forum regulatory/legal seminar provided comprehensive framework
   - 20-year industry veteran (ì´í™êµ­, Asia Medical) insights invaluable for market navigation
   - IRB iterative process understanding (ì†¡ì¬ì§„ advice) prevents perfectionism paralysis

5. **Media Strategy Paying Dividends:**
   - ê¹€ì†Œì—° interview investment yielded two major articles including Gates Foundation feature
   - Press strategy validated: frequent exposure approach confirmed as optimal
   - Media coverage reinforces investor confidence and market credibility

6. **Korean Medicine - Untapped Market:**
   - í•œì˜í•™ exists uniquely in South Korea - represents differentiated market opportunity
   - AI TF advisory role provides inside track to this specialized market
   - Potential for first-mover advantage in Korean Medicine AI integration

7. **Network Effects Compounding:**
   - Middle school friend (ì„±íƒœì›…) connection led to critical medical equipment insights
   - Gauss Labs alumni network (ì´ë³‘ì°¬, ì¡°ì—°í¬) providing ongoing value
   - James Rhee humanities connection expands interdisciplinary perspective
   - Each networking investment generating future returns

8. **Dual Entity Strategy Working:**
   - â‚©500M angel investment in Korea entity enables aggressive local execution
   - USD 140k US entity investment maintains Silicon Valley momentum
   - Path Way Series A commitment for US entity positions for scale
   - Korea entity as Asia market entry point validated

9. **G-Quantum Bio Forum - Major Strategic Event:**
   - 3-day immersion provided:
     - Andrew Radin StartX connection (breakthrough outcome)
     - Silicon Valley-Korea network bridging (ì´ì‹œì—°, ìœ¤ì„±ì›, ë°•êµ°í˜¸)
     - Regulatory/legal comprehensive education
     - Government relations (ê¹€ì„±ì§„, Suwon City)
     - Bio/medical industry landscape visibility
   - Demonstrates value of premier industry events for network acceleration

10. **Time Investment in Relationship Building:**
    - Multiple dinners, coffee chats, and networking sessions paying long-term dividends
    - Semiconductor industry insights from ì±„ê´€ì—½ (multiple meetings) building deep understanding
    - Patient capital approach to network building validated

---

**Report prepared by:** Sunghee Yun  
**Date:** January 5, 2026
